LEADER 01486nas  2200493 a 450 
001 996218750403316
005 20231101152305.0
011   $a1878-5050
035   $a(OCoLC)45218519
035   $a(CKB)110975589362472
035   $a(CONSER)  2004233006
035   $a(DE-599)ZDB2098677-4
035   $a(EXLCZ)99110975589362472
100   $a20001024a20009999  sy              
101 0 $aeng
135   $aurmnu|||||
200 10$aAtherosclerosis$iSupplements
210   $a[Shannon, Ireland] $cElsevier Science Ireland Ltd.$d2000-
300   $aTitle from contents screen (ScienceDirect, viewed Jan. 13, 2004).
300   $aSome issues also have distinctive theme titles.
300   $aRefereed/Peer-reviewed
311   $a1567-5688 
517   $aAtherosclerosis. Supplements
517 3 $aAtherosclerosis supplements
517   $aAtherosclerosis. Supplement
531   $aATHEROSCLEROSIS SUPP
531   $aATHEROSCLEROSIS
531   $aATHEROSCLER SUPPL
531   $aATHEROSCLEROSIS
531 10$aAtheroscler Suppl
531   $aATHEROSCLER. SUPPL
606   $aAtherosclerosis$vPeriodicals
606   $aArteriosclerosis
606   $aResearch
606   $aAthe?roscle?rose$vPe?riodiques
608   $aPeriodical.
615  0$aAtherosclerosis
615  2$aArteriosclerosis.
615  2$aResearch.
615  6$aAthe?roscle?rose
906   $aJOURNAL
912   $a996218750403316
996   $aAtherosclerosis$9729078
997   $aUNISA